Eli Lilly & Co. (LLY): Price and Financial Metrics


Eli Lilly & Co. (LLY): $237.88

1.19 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LLY POWR Grades


  • LLY scores best on the Quality dimension, with a Quality rank ahead of 92.43% of US stocks.
  • The strongest trend for LLY is in Quality, which has been heading down over the past 51 weeks.
  • LLY ranks lowest in Momentum; there it ranks in the 18th percentile.

LLY Stock Summary

  • LLY has a market capitalization of $226,413,131,564 -- more than approximately 99.17% of US stocks.
  • With a one year PEG ratio of 408.17, ELI LILLY & Co is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.69% of US stocks.
  • ELI LILLY & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.68% of US equities in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & Co are PFE, MRK, TXN, INTC, and ABBV.
  • LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.

LLY Valuation Summary

  • LLY's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
  • Over the past 243 months, LLY's price/earnings ratio has gone up 13.
  • LLY's price/earnings ratio has moved up 13 over the prior 243 months.

Below are key valuation metrics over time for LLY.

Stock Date P/S P/B P/E EV/EBIT
LLY 2021-08-31 9.2 38.3 40.7 37.3
LLY 2021-08-30 9.4 38.9 41.3 37.9
LLY 2021-08-27 9.3 38.6 40.9 37.5
LLY 2021-08-26 9.4 38.8 41.2 37.7
LLY 2021-08-25 9.4 39.2 41.6 38.1
LLY 2021-08-24 9.4 39.0 41.4 37.9

LLY Growth Metrics

  • The 4 year price growth rate now stands at 103.4%.
  • The 3 year cash and equivalents growth rate now stands at -11.75%.
  • Its 2 year net income to common stockholders growth rate is now at 392.24%.
Over the past 15 months, LLY's revenue has gone up $3,639,200,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 26,726.3 7,094.7 6,070.7
2021-03-31 25,485.6 7,814.6 6,092.5
2020-12-31 24,539.8 6,499.6 6,193.7
2020-09-30 23,213.8 6,648.1 5,572.6
2020-06-30 22,949.8 6,351.6 5,618.1
2020-03-31 23,087.1 4,907.7 5,533.3

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LLY has a Quality Grade of B, ranking ahead of 92.36% of graded US stocks.
  • LLY's asset turnover comes in at 0.577 -- ranking 64th of 681 Pharmaceutical Products stocks.
  • MRK, BHC, and NBY are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.577 0.743 0.199
2021-03-31 0.568 0.759 0.203
2020-12-31 0.565 0.777 0.214
2020-09-30 0.558 0.783 0.198
2020-06-30 0.573 0.787 0.202
2020-03-31 0.588 0.792 0.200

LLY Price Target

For more insight on analysts targets of LLY, see our LLY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $265.88 Average Broker Recommendation 1.52 (Moderate Buy)

LLY Stock Price Chart Interactive Chart >

Price chart for LLY

LLY Price/Volume Stats

Current price $237.88 52-week high $275.87
Prev. close $236.69 52-week low $129.21
Day low $235.82 Volume 2,598,300
Day high $239.30 Avg. volume 3,444,544
50-day MA $246.66 Dividend yield 1.43%
200-day MA $215.55 Market Cap 228.13B

Eli Lilly & Co. (LLY) Company Bio


Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. (Source:Wikipedia)


LLY Latest News Stream


Event/Time News Detail
Loading, please wait...

LLY Latest Social Stream


Loading social stream, please wait...

View Full LLY Social Stream

Latest LLY News From Around the Web

Below are the latest news stories about ELI LILLY & Co that investors may wish to consider to help them evaluate LLY as an investment opportunity.

Eli Lilly (LLY) Gains But Lags Market: What You Should Know

Eli Lilly (LLY) closed at $237.88 in the latest trading session, marking a +0.5% move from the prior day.

Yahoo | October 15, 2021

The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies

The delta variant's grip on the country has created a gargantuan challenge for companies working on desperately needed treatments, and for Covid stocks.

Yahoo | October 15, 2021

Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?

Smart Beta ETF report for FLQL

Yahoo | October 15, 2021

The FDA Is About to Make Some Major Drug Decisions. What Investors Need to Know.

Food and Drug Administration drug rulings expected in the coming months could affect the stocks of big pharma companies like Pfizer and Eli Lilly, and biotechs.

Yahoo | October 15, 2021

Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology

Eli Lilly and Company (NYSE: LLY) today announced updated data from the positive Phase 3 monarchE trial evaluating the investigational use of Verzenio® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, high risk early breast cancer (EBC). These data were presented at today's ESMO Virtual Plenary and simultaneously published in the Annals of Onco

Yahoo | October 14, 2021

Read More 'LLY' Stories Here

LLY Price Returns

1-mo 2.96%
3-mo 2.66%
6-mo 26.40%
1-year 65.58%
3-year 122.15%
5-year 238.52%
YTD 42.56%
2020 31.04%
2019 16.14%
2018 40.45%
2017 17.83%
2016 -10.37%

LLY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LLY Dividend History

Continue Researching LLY

Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:

ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0578 seconds.